This non-promotional medical education website has been developed by AstraZeneca and is intended for healthcare professionals outside of the US.

Think Aldo Logo
  • Home
  • Expert Network
  • Foundations of Aldosterone
    • Foundations of Aldosterone
    • What is Driving Difficult-to-Control Hypertension?
    • Aldosterone Pathophysiology: Mechanisms and Clinical Consequences
    • A Deep Dive into Aldosterone Dysregulation and its Impact
  • Scientific Resource Library
  • FAQs
  • Home
  • Expert Network
  • Foundations of Aldosterone
    • Foundations of Aldosterone
    • What is Driving Difficult-to-Control
      Hypertension?
    • Aldosterone Pathophysiology:
    • A Deep Dive into Aldosterone
  • Scientific Resource Library
  • FAQs
 
 

Meet Our Experts

Think Aldo is led by a global multidisciplinary network of experts. Click on the pictures below to meet each expert and learn why they are excited about Think Aldo.
Headshot Image of Michael Böhm, Director of the Klinik für Innere Medizin III and Chief of Cardiology, University of Saarland

Professor Michael Böhm, MD, PhD

Director of the Klinik für Innere Medizin III and Chief of Cardiology, University of Saarland

Germany

HeartGermany Flag
Meet the Expert
Luiz Bortolotto, Director of the Hypertension Unit, Professor of Cardiology, Heart Institute of the University of Sao Paulo (InCor)

Professor Luiz Bortolotto, MD, PhD

Director of the Hypertension Unit, Professor of Cardiology, Heart Institute of the University of Sao Paulo (InCor)

Brazil

HeartBrazil Flag
Meet the Expert
Headshot Image of Erika Jones, Associate Professor Of Nephrology And Hypertension, University Of Cape Town

Professor Erika Jones, PhD, FCP, Cert. Nephrol

Associate Professor of Nephrology and Hypertension, University of Cape Town

South Africa

 

HeartSouth Africa Flag
Meet the Expert
Kazuomi Kario, Professor and Chair, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Japan

Dr Kazuomi Kario, MD, PhD, FACC, FAHA, FESC

Professor and Chair, Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine

Japan

HeartJapan Flag
Meet the Expert
Headshot image of Reinhold Kreutz, Professor of Clinical Pharmacology and Hypertension, Charité-Universitätsmedizin, Berlin

Professor Reinhold Kreutz, MD, PhD

Professor of Clinical Pharmacology and Hypertension, Charité-Universitätsmedizin, Berlin

Germany

HeartGernmany Flag
Meet the Expert
Krzysztof Narkiewicz, Professor of Medicine and Head of the Department of Hypertension and Diabetology, Medical University of Gdansk

Professor Krzysztof Narkiewicz, MD, PhD

Professor of Medicine and Head of the Department of Hypertension and Diabetology, Medical University of Gdansk

Poland

HeartPoland Flag
Meet the Expert
Gianfranco Parati MD, FESC, Honorary Professor of Cardiovascular Medicine, Department of Medicine and Surgery, University of Milano-Bicocca

Professor Gianfranco Parati, MD, FESC, ISHDF

Honorary Professor of Cardiovascular Medicine, Department of Medicine and Surgery, University of Milano-Bicocca, Milan
Head, Department of Cardiology and Scientific Director, IRCCS Istituto Auxologico Italiano, Milan
President, World Hypertension League

Italy

HeartItaly Flag
Meet the Expert
Professor Markus Schlaich, Dobney Chair in Clinical Research, The University of Western Australia, Perth

Professor Markus Schlaich, MD, FAHA, FESC, ISHF

Dobney Chair in Clinical Research, The University of Western Australia, Perth

Australia

HeartAustralia Flag
Meet the Expert
Roland Schmieder, Professor of Internal Medicine, Nephrology and Hypertension, University Hospital Erlangen, Germany

Professor Roland Schmieder, MD, FACC, FACP, FASN, FESC

Professor of Internal Medicine, Nephrology and Hypertension, University Hospital Erlangen

Germany

HeartGermany Flag
Meet the Expert
Alta Schutte, Professor of Cardiovascular Medicine, University of New South Wales, Sydney; and Co-Director of the Global Cardiovascular Program, The George Institute for Global Health Sydney

Professor Alta Schutte, PhD, FRSSAf, FESC, ISHF, FAHMS

Professor of Cardiovascular Medicine, University of New South Wales, Sydney

Co-Director of the Global Cardiovascular Program, The George Institute for Global Health Sydney

Australia

HeartAustralia Flag
Meet the Expert
Hirotaka Shibata, Professor and Chair, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University

Professor Hirotaka Shibata, MD, PhD

Professor and Chair, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University

Japan

HeartJapan Flag
Meet the Expert
Rhian M Touyz, Canada Research Chair and Professor of Cardiovascular Medicine, McGill University

Professor Rhian M Touyz MBBCh, PhD, FRCP, FRSE, FMedSci, FRSC

Canada Research Chair and Professor of Cardiovascular Medicine, McGill University, Montreal

Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre, Montreal

Canada

HeartCanada Flag
Meet the Expert
Dr Raymond Townsend, Member of Hypertension Section, Department of Medicine, Perelman School of Medicine, University of Pennsylvania

Dr Raymond Townsend, MD, FAHA

Member of Hypertension Section, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
Professor of Medicine and an Associate Director of the Center for Clinical and Translational Research, University of Pennsylvania

USA

HeartUSA Flag
Meet the Expert
Konstantinos Tsioufis, Professor of Cardiology, Director of 1st Department of Cardiology, University of Athens

Professor Konstantinos Tsioufis, MD, FESC, FACC

Professor of Cardiology, Director of the 1st Department of Cardiology, University of Athens, Hippokration Hospital

Greece

HeartGreece Flag
Meet the Expert
Dr Anand Vaidya, Chief of Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Boston

Dr Anand Vaidya, MD, MMSc

Chief of Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Boston, MA

George W Thorn MD Endowed Chair in Endocrinology

Director of The Center for Adrenal Disorders

Associate Professor of Medicine, Harvard Medical School, Boston, MA

USA

HeartUSA Flag
Meet the Expert
Jiguang Wang, Director of the Department of Hypertension, Rui Jin Hospital, Shanghai Jiao Tong University

Dr Jiguang Wang, MD, PhD, FAHA, FESC

Director of the Department of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

China

HeartChina Flag
Meet the Expert
David Wheeler, Professor of Kidney Medicine, University College London

Professor David Wheeler, MB, CHB, MD, FRCP

Professor of Kidney Medicine, University College London

UK

HeartUK Flag
Meet the Expert
Bryan Williams, Chair of Medicine, University College London

Professor Bryan Williams, OBE, MD, FMedSci

Chair of Medicine, University College London

UK

HeartUK Flag
Meet the Expert

Professor Reinhold Kreutz, MD, PhD

Professor of Clinical Pharmacology and Hypertension, Charité-Universitätsmedizin, Berlin

Germany

Prof. Reinhold Kreutz is the Director of the Department of Clinical Pharmacology and Toxicology at the Charité – Universitätsmedizin in Berlin, Germany. He received the title of Associate Professor in 2010, specialising in hypertension and clinical pharmacology. Prof. Kreutz’s main areas of research are clinical and experimental hypertension with a focus on genetics of hypertensive target organ damage, clinical pharmacology of cardiovascular drugs, pharmacogenomics, drug therapy in the older people and drug safety.

Prof. Kreutz was the President of the European Society of Hypertension (ESH) from 2019 to 2022 and was Secretary of the Scientific Council of ESH (2017–2019). Between 2010 and 2016, he was a member of the management board of the German Society of Hypertension. In addition, he was the Co-Chair of the 2023 ESH Hypertension Guidelines Task Force and the 2024 Clinical Practice Guidelines for the management of hypertension of the ESH.

Prof. Kreutz was awarded an honorary membership of the Polish Society and Hungarian Society of Hypertension in 2022 and 2024, respectively, and an honorary doctorate (honoris causa) in 2022 from the School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.

He has published more than 500 scientific articles and several book chapters related to hypertension and clinical pharmacology. His H-index is 73 (Google Scholar) and ScholarGPS has placed him in the top 0.05% of all scholars worldwide in 2024.

Professor Michael Böhm, MD, PhD

Director of the Klinik für Innere Medizin III and Chief of Cardiology, University of Saarland

Germany

Prof. Michael Böhm is the Director of the Department of Internal Medicine III of the University of Saarland in Germany. He has held prominent positions such as President of the German Society of Cardiology from 2009 to 2011, Board Member of the European Society of Cardiology and is past Editor-in-Chief of the journal Clinical Research in Cardiology. Currently, he is Editor-in-Chief of the European Journal of Heart Failure.

Prof. Böhm has been recognised for his dedication to the field through numerous awards including Arthur Weber Award of the German Society of Cardiology/Heart and Circulation Research, the Franz Groβ Science Award of the German Society of Hypertension, the Franz Loogen Award of the Society for Cardiovascular Research and the Order of Merit of the Federal Republic of Germany.

Prof. Böhm’s clinical and research interests include hypertension, heart failure, interventional cardiology and cardiovascular pharmacology. He is particularly involved in the study of signal transduction during heart failure as well as vascular biology. He has contributed to clinical studies on renal denervation and drug therapies in hypertension and heart failure, and has written around 1100 original research articles, reviews and book chapters, reflecting his significant impact in the field of cardiovascular medicine.

Luiz Bortolotto, MD, PhD

Director of the Hypertension Unit, Professor of Cardiology, Heart Institute of the University of Sao Paulo (InCor)

Brazil

Dr Luiz Bortolotto is a distinguished cardiologist and hypertension specialist based in São Paulo, Brazil. He is the Head of the Hypertension Unit at the Heart Institute (InCor) of the University of São Paulo Faculty of Medical Clinics Hospital (HCFMUSP), where he leads clinical care, research and education in cardiovascular medicine.

Dr Bortolotto has made significant contributions to the understanding and management of arterial hypertension. His research includes vascular ageing, arterial stiffness and central blood pressure, as well as the integration of innovative technologies to enhance patient care. He has authored and co-authored over 350 scientific publications, with research primarily focusing on hypertension.

Dr Bortolotto has also been instrumental in developing multidisciplinary digital health tools aimed at improving blood pressure management and patient adherence. He led the creation of a mobile application designed to monitor home blood pressure readings, medication adherence and lifestyle factors, facilitating remote patient engagement and timely clinical interventions.

Professor Krzysztof Narkiewicz, MD, PhD

Professor of Medicine and Head of the Department of Hypertension and Diabetology, Medical University of Gdansk

Poland

Prof. Krzysztof Narkiewicz is the Head of the Department of Hypertension and Diabetology at the Medical University of Gdansk in Poland. He was the President of the Scientific Council of the European Society of Hypertension (ESH) from 2009 to 2011, the President of the Scientific Council of the Polish Society of Hypertension from 2014 to 2016, and a member of the Taskforce for the Management of Arterial Hypertension of the ESH and of the European Society of Cardiology (ESC) preparing the 2007, 2013 and 2018 guidelines. He also contributed to the 2023 ESH hypertension guidelines.

Prof. Narkiewicz‘s research has been focused on the role of the sympathetic nervous system and metabolic factors in regulating cardiovascular function in physiological and pathological states, and on prevention and treatment of cardiometabolic diseases including hypertension, diabetes, coronary artery disease and congestive heart failure.

He has also published over 430 full-text publications, mainly in the areas of hypertension, cardiovascular disease and metabolic disorders.

Gianfranco Parati, MD, FESC, ISHDF

Honorary Professor of Cardiovascular Medicine, Department of Medicine and Surgery, University of Milano-Bicocca, Milan
Head, Department of Cardiology and Scientific Director, IRCCS Istituto Auxologico Italiano, Milan
President, World Hypertension League

Italy

Prof. Gianfranco Parati is Honorary Professor of Cardiovascular Medicine at the University of Milano-Bicocca and Scientific Director and Head of the Department of Cardiology at IRCCS Istituto Auxologico Italiano in Milan, Italy. He currently serves as President of the World Hypertension League. He is also Immediate Past President of the Council on Hypertension of the European Society of Cardiology, Past President of the Italian Society of Hypertension, a Fellow of the European Society of Cardiology, a Distinguished Fellow of the International Society of Hypertension, and Chairperson of the European Society of Hypertension’s Working Group on Cardiovascular Risk and Hypertension in Low-Resource Settings.

Prof. Parati is Past Executive Editor of the Journal of Hypertension, and currently Associate Editor of Hypertension Research and the European Journal of Preventive Cardiology. He sits on the editorial boards of several leading international journals, including Hypertension.

His research interests include the management of arterial hypertension, blood pressure measurement and variability, sleep-related breathing disorders, arterial stiffness, space research on microgravity (NASA, ESA), high-altitude physiology, cardiac imaging, and the use of telemedicine and digital health technologies.

He has authored more than 1,800 peer-reviewed publications and over 130 book chapters, with an H-index of 147 and 117,544 citations (Research.com).

He was awarded Highly Cited Researcher status by Clarivate in both 2023 and 2024, and received the Research.com Medicine in Italy Leader Award in 2023, 2024, and 2025.

Professor Markus Schlaich, MD, FAHA, FESC, ISHF

Dobney Chair in Clinical Research, The University of Western Australia, Perth

Australia

Prof. Markus Schlaich is a nephrologist and a European Society of Hypertension (ESH) accredited hypertension specialist with a strong background in clinical research. He is the inaugural Dobney Chair in Clinical Research and Winthrop Professor at the University of Western Australia and the Royal Perth Hospital in Australia. Currently, he is Chair of Hypertension Australia, Co-Chair of the Australian National Hypertension Taskforce and is President-Elect of the World Hypertension League.

Prof. Schlaich has been highly successful in attracting competitive grant funding and has authored over 520 publications and book chapters in peer-reviewed journals. He has received multiple national and international research awards including the prestigious Björn Folkow Award from the ESH in 2021.

Prof. Schlaich has made substantial contributions to the understanding of the pathophysiology of hypertension, the role of the renin–angiotensin–aldosterone system, and the development of novel interventional and pharmacological therapeutic approaches. He specialises in a variety of clinical conditions including hypertension, cardiorenal, metabolic and kidney disease.

Professor Roland Schmeider, MD, FACC, FACP, FASN, FESC

Professor of Internal Medicine, Nephrology and Hypertension, University Hospital Erlangen

Germany

Prof. Roland Schmieder is Professor of Internal Medicine, Nephrology and Hypertension, and Head of the Clinical Research Centre in the Department of Nephrology and Hypertension at the University Hospital Erlangen in Germany. He also directs the Institute of Preventative Medicine at the Friedrich Alexander University Erlangen-Nuremberg.

Prof. Schmieder received his postgraduate medical training in nephrology, cardiology and hypertension at the University Hospital of Bonn in Germany, and then at the Alton Ochsner Medical Foundation in New Orleans, USA.

Prof. Schmieder is a member of numerous professional societies and committees and is a Fellow of the American College of Physicians (ACP), American College of Cardiology (ACC), American Society of Nephrology (ASN) and European Society of Cardiology (ESC). He was an author of the 2013, 2018 and 2023 European Society of Hypertension (ESH) guidelines on the management of hypertension. He is also Co-Editor of the book Interventional Therapies of Secondary and Essential Hypertension.

Prof. Schmieder has extensive experience in the execution of clinical studies in the field of hypertension, the renin–angiotensin–aldosterone system, cardiovascular medicine and nephrology, reflected by over 700 publications in peer-reviewed journals.

Professor Alta Schutte, PhD, FRSSAf, FESC, ISHF, FAHMS

Professor of Cardiovascular Medicine, University of New South Wales, Sydney

Co-Director of the Global Cardiovascular Program, The George Institute for Global Health Sydney

Australia

Prof. Alta (Aletta) Schutte is a globally recognised leader in the field of raised blood pressure and hypertension. She has extensive experience in leading randomised clinical trials and several multidisciplinary population-based studies with a focus on raised blood pressure, hypertension and cardiovascular disease, and has published >550 papers in the field.

She is a Trustee of the May Measurement Month global blood pressure screening initiative, an invited author of the Lancet Commission on Hypertension and was the senior author of the 2020 International Society of Hypertension Global Hypertension Guidelines.

In 2022, Prof. Schutte received the Harriet Dustan Award of the American Heart Association; in 2023 and 2024, she was recognised as the leading researcher in ‘Vascular Medicine’ by The Australian; and in 2024, she received the Fiona Stanley Award from the National Health and Medical Research Council as the highest ranked applicant awarded with a $5 million SYNERGY grant.

She serves as Associate Editor of Hypertension and is on the editorial board of several cardiovascular journals. She is the Company Secretary of the Australian Cardiovascular Alliance, Co-Chair of the National Hypertension Taskforce of Australia, and Past President of the International Society of Hypertension.

Professor Hirotaka Shibata, MD, PhD

Professor and Chair, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University

Japan

Prof. Hirotaka Shibata is a Professor and Chair of the Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, at the Oita University in Japan. He is a clinician and researcher specialising in cardiovascular endocrinology, particularly endocrine hypertension and adrenal disorders such as primary aldosteronism, phaeochromocytoma and Cushing syndrome.

Prof. Shibata serves as a Vice President of the Japan Endocrine Society (JES) and as a board member of the Japanese Society of Hypertension (JSH) and leads the Oita University Primary Aldosteronism Research Team (OPAT), which has contributed to the development of clinical practice guidelines for primary aldosteronism in both Japan and the United States.

Prof. Shibata was a Vice Chair for the consensus statement on the Clinical Practice of Primary Aldosteronism in Japan by the JES in 2016. He was also a taskforce member of the Endocrine Society Clinical Practice Guideline of Primary Aldosteronism in 2016 and the JSH Guidelines for the Management of Hypertension in 2019. Prof. Shibata hosted the International Congress of Endocrinology in 2026 (Kyoto, Japan) as a Congress Co-Chair as well as Program Organizing Committee Co-Chair.

Prof. Shibata has co-authored over 140 peer-reviewed publications in the past 15 years, focusing on hypertension and the pathophysiology of primary aldosteronism. Prof. Shibata's recent research includes studies on the mechanisms of mineralocorticoid receptor activation by post-translational modification in diabetes and chronic kidney disease.

Professor Rhian M Touyz MBBCh, PhD, FRCP, FRSE, FMedSci, FRSC

Canada Research Chair and Professor of Cardiovascular Medicine, McGill University, Montreal
Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre, Montreal

Canada

Prof. Touyz is the Canada Research Chair in Cardiovascular Medicine and the Dr. Phil Gold Chair in Medicine McGill University. She is also the British Heart Foundation (BHF) Emeritus Chair. Prior to this, she spent 10 years as Director of the Institute of Cardiovascular and Medical Sciences and BHF Chair and Professor of Cardiovascular Medicine, University of Glasgow in Scotland. Prof. Touyz also directed the BHF Centre of Research Excellence in vascular biomedicine at the University of Glasgow. She is a clinician-scientist with an interest in hypertension.

Prof. Touyz is the Editor-in-Chief of Hypertension and Past Editor of Clinical Science. She was a Committee Member for Guidelines of the European Society of Cardiology (ESC) and co-chaired the 2024 ESC guidelines on hypertension. She has played major leadership roles in premier hypertension organisations, including as President of the Canadian Hypertension Society, Chair of the High Blood Pressure Research Council (American Heart Association [AHA]), President of the International Society of Hypertension (ISH) and President of the European Council of Cardiovascular Research.

Throughout her career, Prof. Touyz has received numerous accolades, such as the Dahl Lecture Award, the Harriet Dustan Award and the Award of Research Excellence, from the Council on Hypertension (AHA). Prof. Touyz has also authored and co-authored over 670 peer-reviewed publications, with a particular focus on hypertension. Her H-index is 155.

Raymond-Townsend

Dr Raymond Townsend, MD, FAHA

Member of Hypertension Section, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
Professor of Medicine and an Associate Director of the Center for Clinical and Translational Research, University of Pennsylvania

USA

Prof. Raymond R. Townsend is Professor of Medicine and an Associate Director of the Center for Clinical and Translational Research at the University of Pennsylvania. His research involves studying factors in the progression of chronic kidney disease and the development and progression of cardiovascular disease in patients with CKD. In addition, he has worked extensively in the area of renal denervation in hypertension therapy and in endocrine forms of hypertension including aldosterone, cortisol and endothelin. His formal certifications are in internal medicine (American Board of Internal Medicine [ABIM]), nephrology (ABIM), clinical pharmacology (American Society for Clinical Pathology) and hypertension (American Society of Hypertension). He is a fellow in the American Heart Association (AHA) and the Council on Hypertension. He was an empanelled member of Eighth Joint National Committee guidelines (JNC 8) and has contributed to the Hypertension Canada Guidelines Committee. He was the AHA Physician of the Year awardee for 2016.

Professor Konstantinos Tsioufis, MD, FESC, FACC

Professor of Cardiology, Director of 1st Department of Cardiology, University of Athens, Hippokration Hospital

Greece

Prof. Konstantinos Tsioufis is the Professor of Cardiology and Director of the 1st Department of Cardiology at the University of Athens, Hippokration Hospital in Greece.

He is currently Vice Dean of the Athens School of Medicine. He has also served as President of the European Society of Hypertension (ESH) from 2017 to 2019, and President of the Hellenic Society of Cardiology from 2016 to 2018. He was also a member of the taskforce for the 2018 European Society of Cardiology (ESC)/ESH hypertension guidelines. Further titles include a fellow of the ESC, a fellow of the American College of Cardiology (ACC), member of the ESC Working Group on Hypertension and the Heart, and member of the ESC.

He has published widely on hypertensive disease, cardiorenal disease, atherosclerotic cardiovascular disease and interventional cardiology, and he is involved in major clinical trials regarding novel interventional therapies for hypertension, particularly renal denervation. He has authored over 800 publications in peer-reviewed journals, is Co-Editor of the book Interventional Therapies of Secondary and Essential Hypertension and he has contributed to more than 25 book chapters in various literature.

Dr Anand Vaidya, MD, MMSc

Chief of Division of Endocrinology, Diabetes and Metabolism, Mass General Brigham, Boston, MA
George W Thorn MD Endowed Chair in Endocrinology
Director of The Center for Adrenal Disorders
Associate Professor of Medicine, Harvard Medical School, Boston, MA

USA

Dr Vaidya is the Director of the Center for Adrenal Disorders and Chief of the Division of Endocrinology, Diabetes, and Hypertension at Mass General Brigham, and an Associate Professor of Medicine at Harvard Medical School. He leads an
NIH-funded translational research laboratory that conducts human physiology studies, mechanistic clinical trials, and population-based studies focused on investigating the role of aldosterone in health and disease.

Dr Vaidya directs the Interactive Medical Case series for the New England Journal of Medicine, created and directed the
pre-clerkship endocrinology curriculum for Harvard medical students in the Pathways curriculum, and routinely teaches practicing clinicians and trainees about adrenal physiology and disease.

Dr Jiguang Wang, MD, PhD, FAHA, FESC

Director of the Department of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

China

Dr Jiguang Wang is Director of both the Shanghai Institute of Hypertension, and the Department of Hypertension at Ruijin Hospital in Shanghai, China. He is also a Professor of Medicine at the Shanghai Jiaotong University School of Medicine.

He is the current President of the Chinese Hypertension League, the Past President of the Pulse of Asia Society and the Asian-Pacific Society of Hypertension. He is also the current Deputy President of the HOPE Asia Network.

Dr Wang serves on the editorial board of multiple journals, including Hypertension Research (Associate Editor), JACC Asia (Section Editor), the Journal of Clinical Hypertension (Editor-in-Chief) and Nature Review Cardiology (Member).

Dr Wang has coordinated several large-scale, multicentre, randomised clinical trials and cohort studies in China, including the Systolic Hypertension in China (Syst-China) trial – the first large-scale hypertension trial involving the Chinese population – contributing significantly to the global understanding of hypertension epidemiology, treatment strategies and clinical outcomes.

He has published over 600 full-length articles on hypertension in the international literature and over 200 articles in the Chinese literature, as well as lecturing extensively at national and international conferences.

Professor David Wheeler, MB, CHB, MD, FRCP

Professor of Kidney Medicine, University College London

UK

Prof. David Wheeler is Professor of Kidney Medicine at University College London (UCL), and Honorary Consultant Nephrologist at the Royal Free Hospital in the UK.

He has developed clinical practice guidelines for several organisations, recently for Kidney Disease: Improving Global Outcomes (KDIGO), of which he was Co-Chair from 2012 to 2019. Previous roles include President of the UK Renal Association and Chair of the UK Renal Registry.

Prof. Wheeler has recently completed a term as Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACTs) Committee. He is currently Research Delivery Network National Specialty Lead for Renal Disorders. At a local level, he is Co-Medical Director of the National Institute for Health and Care Research (NIHR) North Thames Clinical Research Network and lead clinician for the Centre for Clinical Kidney Disease, within the Department of Kidney and Bladder Health at UCL.

He is a clinical scientist interested in the management of chronic kidney disease and has participated in the development and running of several large-scale clinical trials testing therapeutic interventions in kidney disease.

Professor Bryan Williams, OBE, MD, FMedSci

Chair of Medicine, University College London

UK

Prof. Bryan Williams is Chair of Medicine at University College London (UCL), and Chief Scientific and Medical Officer at the British Heart Foundation. He is also a Consultant Physician at University College London Hospitals (UCLH), where he previously served as Director of the National Institute for Health and Care Research (NIHR) UCLH/UCL Biomedical Research Centre and Director of Research for UCLH (2014–2023).

Prof. Williams is recognised globally as one of the leading authorities in hypertension, with research and clinical contributions that have driven major changes in clinical practice worldwide. He has been a frontline National Health Service (NHS) Consultant Physician for 40 years and has received numerous national and international honours, including the Times Higher Education Award for Outstanding Innovation and Technology (2011), the European Society of Hypertension’s Sleight Award (2014) and the World Hypertension League/WHO Research Award (2021). He was awarded the Royal College of Physicians President’s Award in 2023 and an Order of the British Empire (OBE) for services to medicine in the King’s 2024 New Year Honours. In 2022 and 2023, he was listed among the world's most influential and highly cited scientists in clinical research.

Professor Erika Jones, PhD, FCP, Cert. Nephrol

Associate Professor of Nephrology and Hypertension, University of Cape Town

South Africa

Prof. Erika Jones is a nephrologist and hypertension specialist, a consultant in the Division of Nephrology and Hypertension, a consultant in General Medicine and Director of the Kidney and Hypertension Research Unit at the University of Cape Town. She is also the Director of the Hypertension Service, a specialty clinic for resistant and secondary hypertension in young people and women who have had complicated hypertension including during pregnancy.

Prof. Jones is a member of many societies and is the President and Treasurer of the Southern African Hypertension Society and an Executive Council Member for the International Society of Hypertension.

Prof. Jones has published over 50 papers in the fields of hypertension and nephrology. Her clinical interests include all aspects of hypertension and the long-term renal and cardiovascular complications of hypertension during pregnancy. She is also studying the rising incidence of younger people with hypertension and end-stage renal disease in relation to methamphetamine usage. She aspires to improve cardiovascular health, especially in low-resourced settings, and has been an investigator on many clinical trials.

Dr Kazuomi Kario, MD, PhD, FACC, FAHA, FESC

Dr Kazuomi Kario, MD, PhD, FACC, FAHA, FESC Professor and Chair, Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Japan

Japan

Prof. Kazuomi Kario currently serves as President of the Japanese Society of Hypertension, Editor-in-Chief of Hypertension Research and Secretary General of the International Society of Hypertension. He founded the Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network in 2018.

He has developed several blood pressure monitoring devices and has served as Principal Investigator for major clinical studies, including J-HOP, JAMP, COUPLING Japan and WISDOM-Night. He has published more than 1000 academic papers and serves on the editorial boards of multiple international journals. He has received more than 100,000 Google Scholar citations and has an H-index of 130. His work focuses on translating evidence into practice, promoting international collaboration, and training the next generation of clinicians and investigators.

Dr Kazuomi Kario, MD, PhD, FACC, FAHA, FESC

Professor and Chair, Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Japan

Japan

Prof. Kazuomi Kario currently serves as President of the Japanese Society of Hypertension, Editor-in-Chief of Hypertension Research and Secretary General of the International Society of Hypertension. He founded the Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network in 2018.

He has developed several blood pressure monitoring devices and has served as Principal Investigator for major clinical studies, including J-HOP, JAMP, COUPLING Japan and WISDOM-Night. He has published more than 1000 academic papers and serves on the editorial boards of multiple international journals. He has received more than 100,000 Google Scholar citations and has an H-index of 130. His work focuses on translating evidence into practice, promoting international collaboration, and training the next generation of clinicians and investigators.

AstraZeneca Logo
Cookie Policy Legal Notice and Terms of Use Privacy Notice Contact Us Report Adverse Events

©2026 AstraZeneca. All rights reserved. Z4-80196 Last Updated May 2026

Think Aldo logo image

Welcome to Think Aldo

Welcome to Think Aldo, an expert-led initiative advancing knowledge and science around an often overlooked driver of hypertension and cardiovascular and kidney disease: aldosterone.1,2

This website provides the latest scientific insights and educational resources, curated by a network of experts, and is intended for healthcare professionals.

Are you a healthcare professional?

I am not a healthcare professional I am a healthcare professional

This non-promotional medical education website has been developed by AstraZeneca and is intended for healthcare professionals outside of the US.

 

References
1 Papadopoulou-Marketou N, et al. Hyperaldosteronism. In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. 2000
2 Vaidya A, et al. Am J Hypertens 2022;35:967–988
AZ-logo
Legal Notice and Terms of Use Privacy Notice Contact Us Report Adverse Events

©2026 AstraZeneca. All rights reserved. Z4-80196 Last Updated May 2026